Insurers that target diabetes-related medications and supplies for exclusion are being shortsighted. When they fully cover prescribed treatments, insurers permit parents to start their children on the most effective medications and to use them appropriately. As a result, they experience improved clinical outcomes and fewer lifetime medical costs. The cost savings generated by letting doctors drive treatment decisions more than compensates for the higher pharmaceutical costs.
Raed more here.